These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 22168642)

  • 21. Treatment of Sleep Apnea With CPAP Lowers Central and Peripheral Blood Pressure Independent of the Time-of-Day: A Randomized Controlled Study.
    Hoyos CM; Yee BJ; Wong KK; Grunstein RR; Phillips CL
    Am J Hypertens; 2015 Oct; 28(10):1222-8. PubMed ID: 25820243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of a short course of eszopiclone on continuous positive airway pressure adherence: a randomized trial.
    Lettieri CJ; Shah AA; Holley AB; Kelly WF; Chang AS; Roop SA;
    Ann Intern Med; 2009 Nov; 151(10):696-702. PubMed ID: 19920270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea: a randomized controlled trial.
    Phillips CL; Grunstein RR; Darendeliler MA; Mihailidou AS; Srinivasan VK; Yee BJ; Marks GB; Cistulli PA
    Am J Respir Crit Care Med; 2013 Apr; 187(8):879-87. PubMed ID: 23413266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CPAP vs Mandibular Advancement Devices and Blood Pressure in Patients With Obstructive Sleep Apnea: A Systematic Review and Meta-analysis.
    Bratton DJ; Gaisl T; Wons AM; Kohler M
    JAMA; 2015 Dec; 314(21):2280-93. PubMed ID: 26624827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of CPAP therapy on visceral fat thickness, carotid intima-media thickness and adipokines in patients with obstructive sleep apnoea.
    Ng SS; Liu EK; Ma RC; Chan TO; To KW; Chan KK; Ngai J; Yip WH; Ko FW; Wong CK; Hui DS
    Respirology; 2017 May; 22(4):786-792. PubMed ID: 27933703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucose tolerance and cardiovascular risk biomarkers in non-diabetic non-obese obstructive sleep apnea patients: Effects of long-term continuous positive airway pressure.
    Monneret D; Tamisier R; Ducros V; Faure P; Halimi S; Baguet JP; Lévy P; Pépin JL; Borel AL
    Respir Med; 2016 Mar; 112():119-25. PubMed ID: 26847407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eight Hours of Nightly Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea Improves Glucose Metabolism in Patients with Prediabetes. A Randomized Controlled Trial.
    Pamidi S; Wroblewski K; Stepien M; Sharif-Sidi K; Kilkus J; Whitmore H; Tasali E
    Am J Respir Crit Care Med; 2015 Jul; 192(1):96-105. PubMed ID: 25897569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CPAP versus oxygen in obstructive sleep apnea.
    Gottlieb DJ; Punjabi NM; Mehra R; Patel SR; Quan SF; Babineau DC; Tracy RP; Rueschman M; Blumenthal RS; Lewis EF; Bhatt DL; Redline S
    N Engl J Med; 2014 Jun; 370(24):2276-85. PubMed ID: 24918372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial.
    Kohler M; Stoewhas AC; Ayers L; Senn O; Bloch KE; Russi EW; Stradling JR
    Am J Respir Crit Care Med; 2011 Nov; 184(10):1192-9. PubMed ID: 21836134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea.
    Cuhadaroğlu C; Utkusavaş A; Oztürk L; Salman S; Ece T
    Lung; 2009; 187(2):75-81. PubMed ID: 19127383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of CPAP, Weight Loss, or CPAP Plus Weight Loss on Central Hemodynamics and Arterial Stiffness.
    Jain S; Gurubhagavatula I; Townsend R; Kuna ST; Teff K; Wadden TA; Chittams J; Hanlon AL; Maislin G; Saif H; Broderick P; Ahmad Z; Pack AI; Chirinos JA
    Hypertension; 2017 Dec; 70(6):1283-1290. PubMed ID: 29038203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial.
    Barbé F; Durán-Cantolla J; Sánchez-de-la-Torre M; Martínez-Alonso M; Carmona C; Barceló A; Chiner E; Masa JF; Gonzalez M; Marín JM; Garcia-Rio F; Diaz de Atauri J; Terán J; Mayos M; de la Peña M; Monasterio C; del Campo F; Montserrat JM;
    JAMA; 2012 May; 307(20):2161-8. PubMed ID: 22618923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of CPAP on Metabolic Syndrome in Patients With OSA: A Randomized Trial.
    Giampá SQC; Furlan SF; Freitas LS; Macedo TA; Lebkuchen A; Cardozo KHM; Carvalho VM; Martins FC; Azam IFB; Costa-Hong V; Lopes HF; Baptista ML; Rochitte CE; Bortolotto LA; Lorenzi-Filho G; Drager LF
    Chest; 2022 May; 161(5):1370-1381. PubMed ID: 35063452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of Blood Pressure Fall With Continuous Positive Airway Pressure Treatment in Hypertension With Coronary Artery Disease and Obstructive Sleep Apnea.
    Huang Z; Liu Z; Luo Q; Zhao Q; Zhao Z; Ma X; Xi Q; Yang D
    Can J Cardiol; 2015 Jul; 31(7):853-9. PubMed ID: 25660149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obstructive sleep apnea syndrome and arterial hypertension--a complicated relationship? The role of controlling blood pressure values in patients with OSAS.
    Deleanu OC; Mălăuţ AE; Nebunoiu AM; Micheu MM; Mihălţan FD
    Pneumologia; 2014; 63(1):36-43. PubMed ID: 24800594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CPAP treatment of a population-based sample--what are the benefits and the treatment compliance?
    Lindberg E; Berne C; Elmasry A; Hedner J; Janson C
    Sleep Med; 2006 Oct; 7(7):553-60. PubMed ID: 16740408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of an intensive weight-loss program for severe OSA in patients undergoing CPAP treatment: a randomized controlled trial.
    López-Padrós C; Salord N; Alves C; Vilarrasa N; Gasa M; Planas R; Montsserrat M; Virgili MN; Rodríguez C; Pérez-Ramos S; López-Cadena E; Ramos MI; Dorca J; Monasterio C
    J Clin Sleep Med; 2020 Apr; 16(4):503-514. PubMed ID: 32003737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An assessment of oxidized LDL in the lipid profiles of patients with obstructive sleep apnea and its association with both hypertension and dyslipidemia, and the impact of treatment with CPAP.
    Feres MC; Fonseca FA; Cintra FD; Mello-Fujita L; de Souza AL; De Martino MC; Tufik S; Poyares D
    Atherosclerosis; 2015 Aug; 241(2):342-9. PubMed ID: 26071656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obstructive sleep apnea and blood pressure. Interaction between the blood pressure-lowering effects of positive airway pressure therapy and antihypertensive drugs.
    Börgel J; Sanner BM; Keskin F; Bittlinsky A; Bartels NK; Büchner N; Huesing A; Rump LC; Mügge A
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1081-7. PubMed ID: 15607612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea.
    McEvoy RD; Antic NA; Heeley E; Luo Y; Ou Q; Zhang X; Mediano O; Chen R; Drager LF; Liu Z; Chen G; Du B; McArdle N; Mukherjee S; Tripathi M; Billot L; Li Q; Lorenzi-Filho G; Barbe F; Redline S; Wang J; Arima H; Neal B; White DP; Grunstein RR; Zhong N; Anderson CS;
    N Engl J Med; 2016 Sep; 375(10):919-31. PubMed ID: 27571048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.